StockWatch
·
Healthcare Research- Analytics & Technology
Shareholding10 Aug 2026, 11:18 am

BPC Genesis Fund Sells 5.76% Stake in Indegene Ltd

AI Summary

BPC Genesis Fund I SPV Ltd has disclosed the sale of its entire stake in Indegene Limited, amounting to 13,862,223 equity shares. This represents 5.757% of the total share capital and 5.741% of the total diluted share capital. The sale was conducted via open market transactions on the NSE. Following this transaction, BPC Genesis Fund I SPV Ltd holds no shares in Indegene Limited. The disclosure was made under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Key Highlights

  • BPC Genesis Fund I SPV Ltd sold its entire 5.76% stake in Indegene.
  • Transaction involved 13,862,223 equity shares.
  • Sale executed through open market transactions on NSE.
  • Disclosure made under SEBI (SAST) Regulations, 2011.
  • Seller no longer holds any shares in Indegene.